Improvement of Transition From Hospital to Home for Older Patients in Germany

NCT03513159 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 252

Last updated 2021-03-03

No results posted yet for this study

Summary

The aim of the transsectoral care project TIGER is the reduction of readmission rates of geriatric patients. This aim shall be achieved by improving the hitherto inadequate care process for geriatric patients in the transition from hospital to home. The program offers substantial support of patients and their informal caregivers in the transition process from hospital to home via so called pathfinders, specialized nurses in geriatrics.The pathfinders effectively intertwine stationary and ambulatory care teams caring for a patient, thereby augmenting and complementing effective hospital release management.

Conditions

  • Geriatric Patients in the Transition From Hospital to Home

Interventions

BEHAVIORAL

Pathfinder support

A pathfinder will support the patient with structured activities.

Sponsors & Collaborators

  • Hospital of the Order of St.John of God Regensburg, Barmherzige Brueder, Germany

    collaborator UNKNOWN
  • Regensburg Physicians Network RAEN

    collaborator UNKNOWN
  • Friedrich-Alexander-Universität Erlangen-Nürnberg

    collaborator OTHER
  • AOK Bayern

    collaborator INDUSTRY
  • Institute for Nursing Sciences, University of Bielefeld, Germany

    collaborator UNKNOWN
  • Federal Association for Geriatrics, Germany

    collaborator UNKNOWN
  • Federal Joint Committee

    collaborator OTHER_GOV
  • Institute for Community Medicine, University of Greifswald, Germany

    collaborator UNKNOWN
  • University of Erlangen-Nürnberg Medical School

    lead OTHER

Principal Investigators

  • Cornel Sieber, Prof. Dr. · Institute for Biomedicine of Aging

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-25
Primary Completion
2020-06-30
Completion
2021-02-28

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03513159 on ClinicalTrials.gov